Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Integra Lifesciences (NQ: IART )

19.48 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Integra Lifesciences

< Previous 1 2 3 4 Next >
Unveiling 10 Analyst Insights On Integra Lifesciences
Via Benzinga
Expert Outlook: Integra Lifesciences Through The Eyes Of 8 Analysts
Via Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, Aug. 3
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of July 29 through Aug. 2. 
Via Talk Markets
Integra LifeSciences Analysts Cut Their Forecasts After Q2 Results
Via Benzinga
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
NASDAQ:IART is an undervalued gem with solid fundamentals.
INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is an undervalued gem with solid fundamentals. 
Via Chartmill
Why Integra Lifesciences Stock Is Sinking Today
Q2 revenue and earnings beats didn't make up for the company's full-year guidance cut. 
Via The Motley Fool
Topics Earnings
Exposures Financial
IART Stock Earnings: Integra Lifesciences Beats EPS, Beats Revenue for Q2 2024
IART stock results show that Integra Lifesciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
The 3 Best Brain-Computer Interface Stocks to Buy Now
With the number of U.S. citizens aged 65 and above growing to 55.8 million, we could see brain-computer interface stocks accelerate. 
Via InvestorPlace
8 Analysts Have This To Say About Integra Lifesciences
Via Benzinga
For those who appreciate value investing, NASDAQ:IART is a compelling option with its solid fundamentals.
INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART), an undervalued stock with good fundamentals. 
Via Chartmill
A Glimpse Into The Expert Outlook On Integra Lifesciences Through 8 Analysts
Via Benzinga
Analyst Scoreboard: 5 Ratings For Integra Lifesciences
Via Benzinga
Recap: Integra Lifesciences Q4 Earnings
Via Benzinga
NASDAQ:IART appears to be flying under the radar despite its strong fundamentals.
Despite its impressive fundamentals, INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) remains undervalued. 
Via Chartmill
CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
KKR and GoDaddy also will join before the open on June 24. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
$1.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
NASDAQ:IART is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Investors should take notice ofINTEGRA LIFESCIENCES HOLDING (NASDAQ:IART)—it offers a great deal for the fundamentals it presents. 
Via Chartmill
The Analyst Landscape: 7 Takes On Integra Lifesciences
Via Benzinga
Stocks On Track For Third Green Session, Palantir Ignites Rally In Chipmakers, Commodities Rebound: What's Driving Markets Monday?
The stock market is poised to mark a third consecutive session of gains, with major indices all trading in the green during midday trading in New York on Monday, as traders continue to react positively... 
Via Benzinga
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
Via Benzinga
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Is Medical Device Maker Integra LifeSciences Stock Falling On Monday?
Integra LifeSciences surpasses expectations with first-quarter revenues of $368.9 million, reporting growth in Codman Specialty Surgical and updates fiscal year 2024 guidance. 
Via Benzinga
IART Stock Earnings: Integra Lifesciences Meets EPS, Beats Revenue for Q1 2024
IART stock results show that Integra Lifesciences met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
NASDAQ:IART is probably undervalued for the fundamentals it is displaying.
INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. 
Via Chartmill
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
NASDAQ:IART, an undervalued stock with good fundamentals.
INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. 
Via Chartmill
Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal
Integra LifeSciences Holdings Corporation (NASDAQ: IART) agreed to acquire Acclarent Inc. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.